首页> 外文期刊>Journal of psychiatric research >BDNF Val66Met and childhood adversity on response to physical exercise and internet-based cognitive behavioural therapy in depressed Swedish adults
【24h】

BDNF Val66Met and childhood adversity on response to physical exercise and internet-based cognitive behavioural therapy in depressed Swedish adults

机译:BDNF Val66Met和儿童逆境有关抑郁瑞典成年人的响应体育锻炼和基于互联网的认知行为治疗的逆境

获取原文
获取原文并翻译 | 示例
           

摘要

The genetic effect of Brain-derived neurotrophic factor (BDNF) on treatment response in depression is not consistent in the literature. Childhood adversity is a known risk factor for depression which has been reported to increase depression susceptibility by interacting with BDNF genetic variation. We aimed to explore whether the BDNF variation Val66Met and childhood adversity (CA) predicted the treatment response to a 12-week intervention with physical exercise (PE) or internet-based cognitive behavioural therapy (ICBT) when compared with treatment as usual (TAU). A prospective cohort study nested within a randomised control trial was conducted using data from 547 participants with mild to moderate depression. Depression severity at baseline and follow-up was measured using the Montgomery-Asberg Depression Rating Scale. Met allele carriers without exposure to CA and current antidepressant use showed higher treatment response to PE than Val homozygotes. There was no evidence to support that BDNF Val66Met or CA alone predicted treatment response to PE and ICBT. The Met carriers had higher serum mature BDNF level. These data suggest that Met allele carriers benefit more from PE treatment but only if they are not exposed to early adversity. (C) 2017 Elsevier Ltd. All rights reserved.
机译:脑衍生的神经营养因子(BDNF)对抑郁症治疗反应的遗传效应在文献中并不一致。儿童逆境是一种已知的抑郁危险因素,据报道,通过与BDNF遗传变异相互作用来增加抑郁症易感性。我们旨在探讨BDNF变异Val66met和儿童逆境(CA)预测治疗响应与常规(TAU)相比(TAU)的治疗(互联网)或基于互联网的认知行为治疗(ICBT)的治疗反应。使用来自547名参与者的数据进行随机对照试验中嵌套在随机控制试验中的预期队列研究。使用Montgomery-Asberg抑郁率刻度测量基线和随访时的抑郁严重程度。遇到的等位基因携带者没有暴露于CA和电流抗抑郁用途,对PE的治疗响应较高而不是Val Homozygotes。没有证据支持BDNF Val66met或Ca单独预测对PE和ICBT的治疗响应。 Met载体具有更高的血清成熟BDNF水平。这些数据表明,满足等位基因载体从PE治疗中受益更多,但只有它们没有暴露于早期逆境。 (c)2017 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号